And so, another work week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Today, however, we are daydreaming about a lengthy and overdue break. Our agenda is modest, but important: We intend to hang with all of our short people, indulge Mrs. Pharmalot and visit the Pharmalot ancestors. Of course, we will take a few naps, too. And what about you? This is a lovely time of year to enjoy special people or the great outdoors. You could make a resolution or simply ponder the future. Well, whatever you do, we hope you have a grand time and enjoy whatever celebrations come your way. See you next year, as they say…but you can still enjoy next week’s Pharmalittle column, which will come at you Tuesday through Friday from guest authors.

Drug makers selling opioid painkillers hired at least 42 officials from the US Drug Enforcement Administration as the agency began cracking down on companies that were distributing an inordinate numbers of pills, such as oxycodone, to pain-management clinics and pharmacies around the country, The Washington Post reports. And 31 of those people came directly from the division responsible for regulating the industry.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy